INSTYTUT BIOFARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

01/02/2019

VAT status

Active

Bankruptcy proceedings

No proceedings

INSTYTUT BIOFARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated due to ongoing/recent liquidation proceedings.

Incorporation date

28/01/2019

Share capital

100,000.00 PLN

Primary activity

Manufacture of basic pharmaceutical products (21.10.Z - PKD 2007)

Representatives

Representatives rights

W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO DO REPREZENTOWANIA SPÓŁKI UPRAWNIONY JEST PREZES ZARZĄDU SAMODZIELNIE A CZŁONEK ZARZĄDU ŁĄCZNIE Z PREZESEM ZARZĄDU LUB CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM.

Representatives

No representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
-	-

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

-31,106

Net Profit (zł)

-31,106

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
200
-19,739
-19,739
8.81
2.97
-9,869.50
-4,244
893
62,917
56,910

2023
200
-15,531
-15,531
2.65
1.77
-7,765.50
-19,776
689
69,085
48,780

2024
5,500
-31,106
-31,106
1.57
13.53
-565.56
-50,882
689
100,166
40,650

2024
5,500
-31,106
-31,106
1.57
13.53
-565.56
-50,882
689
100,166
40,650

Turnover (zł)

2024

Turnover (zł)

5,500 zł2,650 % *

Profit before tax (zł)

-31,106 zł-100 % *

Net Profit (zł)

-31,106 zł-100 % *

Working capital requirement (%)

1.57 -40.75 % *

Liquidity ratio

13.53 664.41 % *

Net profitability (%)

-565.56 %92.72 % *

Equity (zł)

-50,882 zł-157 % *

Current liabilities (zł)

689 zł0 % *

Non current liabilities (zł)

100,166 zł45 % *

Non-current Assets (zł)

40,650 zł-17 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

INSTYTUT BIOFARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI Documents

Date	Description
04/07/2025	OD 01.01.2024 DO 31.12.2024
02/07/2024	OD 01.01.2023 DO 31.12.2023
10/10/2023	OD 01.01.2022 DO 31.12.2022
29/11/2022	OD 01.01.2021 DO 31.12.2021
14/07/2022	OD 01.01.2020 DO 31.12.2020